These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25798431)

  • 21. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding.
    Busfield RA; Farquhar CM; Sowter MC; Lethaby A; Sprecher M; Yu Y; Sadler LC; Brown P; Johnson N
    BJOG; 2006 Mar; 113(3):257-63. PubMed ID: 16487195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A single-arm phase III study exploring the efficacy and safety of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5 mg), in an Asia-Pacific population.
    Fan G; Kang S; Ren M; Weisberg E; Lukkari-Lax E; Roth K; Shin S
    Contraception; 2017 Apr; 95(4):371-377. PubMed ID: 27913229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Five-year follow-up of levonorgestrel-releasing intrauterine system versus thermal balloon ablation for the treatment of heavy menstrual bleeding: a randomized controlled trial.
    Silva-Filho AL; Pereira Fde A; de Souza SS; Loures LF; Rocha AP; Valadares CN; Carneiro MM; Tavares RL; Camargos AF
    Contraception; 2013 Apr; 87(4):409-15. PubMed ID: 23228505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mifepristone treatment prior to insertion of a levonorgestrel releasing intrauterine system for improved bleeding control - a randomized controlled trial.
    Papaikonomou K; Kopp Kallner H; Söderdahl F; Gemzell-Danielsson K
    Hum Reprod; 2018 Nov; 33(11):2002-2009. PubMed ID: 30295731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levonorgestrel-releasing intrauterine system for treatment of heavy menstrual bleeding in adolescents with Glanzmann's Thrombasthenia: illustrated case series.
    Lu M; Yang X
    BMC Womens Health; 2018 Feb; 18(1):45. PubMed ID: 29486748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness analysis in the treatment of heavy menstrual bleeding in Spain.
    Calaf J; Lete I; Canals I; Crespo C; Espinós B; Cristóbal I
    Eur J Obstet Gynecol Reprod Biol; 2015 Jan; 184():24-31. PubMed ID: 25462215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
    Sturridge F; Guillebaud J
    Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levonorgestrel intrauterine system versus thermal balloon ablation for the treatment of heavy menstrual bleeding: A meta-analysis of randomized controlled trials.
    Yang BQ; Xu JH; Teng YC
    Exp Ther Med; 2015 Nov; 10(5):1665-1674. PubMed ID: 26640534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case series on the use of levonorgestrel 52 mg intrauterine system after organ transplant.
    Juliato CRT; Stahlschmidt P; Fernandes A; Monteiro I; Bahamondes L
    Contraception; 2018 Sep; 98(3):252-254. PubMed ID: 29746814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does a Bleeding Disorder Lessen the Efficacy of the 52-mg Levonorgestrel-Releasing Intrauterine System for Heavy Menstrual Bleeding in Adolescents? A Retrospective Multicenter Study.
    Khalighi M; Wheeler AP; Adeyemi-Fowode OA; Kouides PA; Durazo-Arvizu RA; Haley K; Dersch CM; Weyand AC; Baldwin MK; Borzutzky C
    J Adolesc Health; 2022 Aug; 71(2):204-209. PubMed ID: 35430143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Chin J; Konje JC; Hickey M
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007245. PubMed ID: 19821400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of the levonorgestrel-releasing intrauterine system position on bleeding patterns in reproductive age women.
    Alves RDMS; Rabelo MM; Andrade VR; Cabral RCS; Merriman JW; Brito MB
    Int J Gynaecol Obstet; 2019 Dec; 147(3):326-331. PubMed ID: 31489621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial.
    Shaaban OM; Ali MK; Sabra AM; Abd El Aal DE
    Contraception; 2015 Oct; 92(4):301-7. PubMed ID: 26071673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the use of two new low-dose levonorgestrel-releasing intrauterine systems as contraceptives.
    Bahamondes L; Bahamondes MV
    Womens Health (Lond); 2012 May; 8(3):235-8. PubMed ID: 22554171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The levonorgestrel intrauterine system: more than a contraceptive.
    Andersson K
    Eur J Contracept Reprod Health Care; 2001; 6 Suppl 1():15-22. PubMed ID: 25104510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effectiveness of Levonorgestrel-Releasing Intrauterine System in the Treatment of Heavy Menstrual Bleeding.
    Eralil GJ
    J Obstet Gynaecol India; 2016 Oct; 66(Suppl 1):505-12. PubMed ID: 27651654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of the Levonorgestrel-Releasing Intrauterine System in the Treatment of Abnormal Uterine Bleeding and Dysmenorrhea: A Narrative Review.
    Bianchi P; Guo SW; Habiba M; Benagiano G
    J Clin Med; 2022 Oct; 11(19):. PubMed ID: 36233703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
    Wildemeersch D; Janssens D; Andrade A
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selection and performance of the levonorgestrel-releasing intrauterine system.
    Lähteenmäki P; Bardin CW; Elomaa K; Haukkamaa M; Kivijärvi A; Kuukankorpi A; Venhola M; Tuominen J
    Acta Obstet Gynecol Scand Suppl; 1997; 164():69-74. PubMed ID: 9225643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.